Abstract
Amphotericin B, flucytosine, fluconazole, and voriconazole alone and in combination were evaluated against isolates of Candida lusitaniae. MICs were determined by broth microdilution and Etest, and time-kill studies were conducted. Amphotericin B resulted in fungicidal activity against most isolates, whereas fluconazole, voriconazole, and flucytosine produced primarily fungistatic activities. The addition of flucytosine to amphotericin B resulted in a faster rate and greater extent of kill for isolates for which the MICs of amphotericin B were elevated.
MeSH Terms
Amphotericin B/pharmacology
Antifungal Agents/pharmacology
Candida/drug effects
Fluconazole/pharmacology
Flucytosine/pharmacology
Humans
Microbial Sensitivity Tests/methods
Pyrimidines/pharmacology
Time Factors
Triazoles/pharmacology
Voriconazole
Chemicals
Antifungal Agents
Pyrimidines
Triazoles
Amphotericin B
Fluconazole
Flucytosine
Voriconazole
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ernst Erika J
College of Pharmacy, The University of Iowa, Iowa City, Iowa 52242, USA.
[email protected]
Yodoi Keiko
Roling Ellen E
Klepser Michael E
References (11)
11 references, click to expand
-
Emergence of a new opportunistic pathogen, Candida lusitaniae.
J Clin Microbiol. 1989 Feb;27(2):236-40
PMID: 2644291
-
Mycoses caused by Candida lusitaniae.
Rev Infect Dis. 1987 Sep-Oct;9(5):1006-12
PMID: 3317728
-
Strain delineation and antifungal susceptibilities of epidemiologically related and unrelated isolates of Candida lusitaniae.
Diagn Microbiol Infect Dis. 1994 Nov;20(3):127-33
PMID: 7874879
-
Detection of amphotericin B-resistant Candida isolates in a broth-based system.
Antimicrob Agents Chemother. 1995 Apr;39(4):906-9
PMID: 7785993
-
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates.
Antimicrob Agents Chemother. 1995 Nov;39(11):2520-2
PMID: 8585737
-
Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans.
Antimicrob Agents Chemother. 1997 Jun;41(6):1392-5
PMID: 9174207
-
In-vitro susceptibility pattern of Candida lusitaniae and evaluation of the Etest method.
J Antimicrob Chemother. 1997 May;39(5):591-6
PMID: 9184357
-
Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia.
Br J Haematol. 1997 Jun;97(3):663-5
PMID: 9207418
-
Therapeutic drug monitoring of systemic antifungal therapy.
J Antimicrob Chemother. 1997 Dec;40(6):753-64
PMID: 9462426
-
Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.
Antimicrob Agents Chemother. 1998 Jun;42(6):1382-6
PMID: 9624480
-
In vitro interaction of fluconazole and amphotericin B administered sequentially against Candida albicans: effect of concentration and exposure time.
Diagn Microbiol Infect Dis. 1998 Nov;32(3):205-10
PMID: 9884837